Elanco Animal Health Inc— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$1.14B
↑+12.2% +$124Mvs FY2024 (Q4)
Gross Profit
$589M
↑+13.5% +$70Mvs FY2024 (Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $1.14B | $1.02B |
| COGS | $555M | $501M |
| Gross Profit | $589M | $519M |
| R&D | $93M | $81M |
| SG&A | $338M | $300M |
| D&A | $174M | $164M |
| Other OpEx | $0 | $0 |
| Operating Income | $0 | $0 |
| Interest Exp. | $0 | $0 |
| Other Non-Op | $0 | $0 |
| Pretax Income | $0 | $0 |
| Tax | $0 | $0 |
| Net Income | $0 | $0 |
QuarterCharts · SEC EDGAR data · ELAN · Comparing FY2025 (Q4) vs FY2024 (Q4)